Patents by Inventor Cecilia A. W. Geuijen

Cecilia A. W. Geuijen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8460666
    Abstract: Described are human binding molecules specifically binding to staphylococci and having killing activity against staphylococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from Staphylococcus.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: June 11, 2013
    Assignee: Crucell Holland B.V.
    Inventors: Mark Throsby, Cecilia A. W. Geuijen, Cornelis Adriaan De Kruif
  • Patent number: 8211431
    Abstract: The present invention provides human binding molecules specifically binding to staphylococci and having killing activity against staphylococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from Staphylococcus.
    Type: Grant
    Filed: June 5, 2007
    Date of Patent: July 3, 2012
    Assignee: Crucell Holland B.V.
    Inventors: Mark Throsby, Cecilia A. W. Geuijen, Cornelis Adriaan De Kruif
  • Publication number: 20120141493
    Abstract: Described are human binding molecules specifically binding to staphylococci and having killing activity against staphylococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from Staphylococcus.
    Type: Application
    Filed: February 15, 2012
    Publication date: June 7, 2012
    Applicant: Crucell Holland B.V.
    Inventors: Mark Throsby, Cecilia A.W. Geuijen, Cornelis Adriaan De Kruif
  • Publication number: 20100297153
    Abstract: Provided are new tumor-associated antigens, binding molecules that specifically bind to the antigens, nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules, and methods of identifying or producing the binding molecules. The tumor-associated antigens are expressed on cancer cells and binding molecules capable of specifically binding to the antigens can be used in the diagnosis, prevention and/or treatment of cancer.
    Type: Application
    Filed: June 18, 2010
    Publication date: November 25, 2010
    Inventors: Cecilia A.W. Geuijen, Cornelis A. de Kruif
  • Publication number: 20090104204
    Abstract: The present invention provides human binding molecules specifically binding to staphylococci and having killing activity against staphylococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the human binding molecules. The human binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from Staphylococcus.
    Type: Application
    Filed: June 5, 2007
    Publication date: April 23, 2009
    Inventors: Mark Throsby, Cecilia A.W. Geuijen, Cornelis Adriaan De Kruif